Published On July 21–22, 2025, the Faculty of Medicine Siriraj Hospital, Mahidol University, had the esteemed privilege of hosting the second on-site visit of the Scientific Advisory Board (SAB) of the Siriraj Center of Research Excellence in Cancer Precision Medicine and Systems Pharmacology (SiCORE–PM&SP). This visit, which featured comprehensive tours of our research laboratories and in-depth discussions on the center’s research progress and strategic direction, was a significant milestone in our journey.
The event was formally opened by Prof. Sith Sathornsumetee, Deputy Dean for Research and Innovation, who represented the Dean and served as Chair of the meeting. Assist. Prof. Dr. Woraphat Ratta-apha, Head of the Center of Research Excellence, moderated the first day of the meeting, while Assist. Prof. Somponnat Sampattavanich, Director of SiCORE–PM&SP, served as moderator on the second day.
A highlight of the visit was a series of distinguished lectures by SAB members and invited speakers, who shared their pioneering research and expert insights in cancer science, showcasing their unparalleled expertise in the field:
🌟 Prof. Andrew Futreal, Ph.D.
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, USA
Lecture: “Eliminating ‘luck’ – Learning from rare cancer patients to improve outcomes.”
🌟Prof. Ruby Yun-Ju Huang, M.D., Ph.D.
School of Medicine, College of Medicine, National Taiwan University
Lecture: “Gazing the Epithelial-Mesenchymal Plasticity Spectrum in Multi-omics Dimensions.”
🌟Prof. Eric C. Schirmer, Ph.D.
Institute of Cell Biology, School of Biological Sciences, The University of Edinburgh, Scotland
Lecture: “Rectifying nuclear size changes to reduce metastatic spread.”
The SiCORE-M and SiCORE–Cancer PM&SP teams would like to express our sincere appreciation to the SAB members and esteemed guest speakers for their invaluable contributions, generous time, and unwavering support. We eagerly anticipate the future collaboration and knowledge exchange as we advance the frontiers of cancer precision medicine and systems pharmacology.
